Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

4.490

-0.120 (-2.60%)

At close: Mar 13, 2026, 4:00 PM EDT

4.460

-0.030 (-0.67%)

After-hours: Mar 13, 2026, 5:44 PM EDT

Taysha Gene Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	299.94	141.64	146.54	90.52	151.74	251.25
Cash & Short-Term Investments	299.94	141.64	146.54	90.52	151.74	251.25
Cash Growth	87.13%	-3.35%	61.89%	-40.35%	-39.61%	-
Other Current Assets	2.16	2.65	5.48	8.54	10.5	6.63
Total Current Assets	299.95	142.13	149.87	96.42	159.6	257.88
Net Property, Plant & Equipment	14.27	15.87	20.41	25.91	50.61	1
Other Long-Term Assets	0.18	0.22	0.3	1.32	1.11	-
Total Assets	316.55	160.36	172.73	126.28	213.96	258.88
Accounts Payable	5.44	3.59	6.37	10.95	21.76	1.99
Accrued Expenses	17.71	12.86	12.28	18.29	29.98	5.14
Unearned Revenue	5.49	9.77	18.11	33.56	-	-
Total Current Liabilities	28.63	26.23	36.76	62.79	51.75	7.13
Long-Term Debt	50.85	43.94	40.51	37.97	37.19	-
Long-Term Leases	16.51	17.36	18.95	20.44	25.9	-
Other Long-Term Liabilities	1.58	1.31	1.58	4.13	3.74	0.45
Total Long-Term Liabilities	68.93	62.61	61.04	62.54	66.83	0.45
Total Liabilities	97.57	88.84	97.79	125.33	118.57	7.58
Common Stock	0	0	0	0	-	-
Additional Paid-in Capital	903.58	677.86	587.94	402.39	331.03	312.43
Accumulated Other Comprehensive Income	-1.14	-4.03	-	-	-	-
Retained Earnings	-683.45	-602.31	-513.01	-401.44	-235.65	-61.13
Shareholders' Equity	218.99	71.53	74.94	0.95	95.38	251.3
Total Liabilities & Equity	316.55	160.36	172.73	126.28	213.96	258.88
Total Debt	67.36	61.3	59.46	58.41	63.09	0
Net Cash (Debt)	232.59	80.33	87.08	32.11	88.65	251.25
Net Cash Growth	189.53%	-7.75%	171.19%	-63.78%	-64.72%	-
Net Cash Per Share	0.78	0.32	0.75	0.73	2.35	14.22
Book Value	218.99	71.53	74.94	0.95	95.38	251.3
Book Value Per Share	0.74	0.29	0.65	0.02	2.53	14.23
Tangible Book Value	218.99	71.53	74.94	0.95	95.38	251.3
Tangible Book Value Per Share	0.74	0.29	0.65	0.02	2.53	14.23

Updated Nov 4, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q